Correlation Between Neurocrine Biosciences and TC BioPharm

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Neurocrine Biosciences and TC BioPharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurocrine Biosciences and TC BioPharm into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neurocrine Biosciences and TC BioPharm plc, you can compare the effects of market volatilities on Neurocrine Biosciences and TC BioPharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurocrine Biosciences with a short position of TC BioPharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurocrine Biosciences and TC BioPharm.

Diversification Opportunities for Neurocrine Biosciences and TC BioPharm

-0.46
  Correlation Coefficient

Very good diversification

The 3 months correlation between Neurocrine and TCBPW is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding Neurocrine Biosciences and TC BioPharm plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TC BioPharm plc and Neurocrine Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurocrine Biosciences are associated (or correlated) with TC BioPharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TC BioPharm plc has no effect on the direction of Neurocrine Biosciences i.e., Neurocrine Biosciences and TC BioPharm go up and down completely randomly.

Pair Corralation between Neurocrine Biosciences and TC BioPharm

Given the investment horizon of 90 days Neurocrine Biosciences is expected to generate 71.96 times less return on investment than TC BioPharm. But when comparing it to its historical volatility, Neurocrine Biosciences is 15.61 times less risky than TC BioPharm. It trades about 0.02 of its potential returns per unit of risk. TC BioPharm plc is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  2.90  in TC BioPharm plc on September 2, 2024 and sell it today you would lose (1.03) from holding TC BioPharm plc or give up 35.52% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Neurocrine Biosciences  vs.  TC BioPharm plc

 Performance 
       Timeline  
Neurocrine Biosciences 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Neurocrine Biosciences are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong forward indicators, Neurocrine Biosciences is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.
TC BioPharm plc 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in TC BioPharm plc are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, TC BioPharm showed solid returns over the last few months and may actually be approaching a breakup point.

Neurocrine Biosciences and TC BioPharm Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Neurocrine Biosciences and TC BioPharm

The main advantage of trading using opposite Neurocrine Biosciences and TC BioPharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurocrine Biosciences position performs unexpectedly, TC BioPharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TC BioPharm will offset losses from the drop in TC BioPharm's long position.
The idea behind Neurocrine Biosciences and TC BioPharm plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Complementary Tools

Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Share Portfolio
Track or share privately all of your investments from the convenience of any device